Obsidian Therapeutics secures $350 million through a private placement. The funds will support its development of engineered tumor-infiltrating lymphocyte cell therapies.
Amount Raised
$350 Million
Round Type
Post-IPO Equity
CambridgeBiotechnologyHealth CareDescription
Obsidian Therapeutics, Inc. announced the completion of its private placement of $350 million. This funding will aid in the advancement of their innovative therapies. The transaction is part of their strategic partnership with Galera Therapeutics
Quick answer
Obsidian Therapeutics raised $350 Million in a Post-IPO Equity round, dated August 3, 2026. Obsidian Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Obsidian Therapeutics raise?
- Obsidian Therapeutics raised $350 Million in a Post-IPO Equity round on August 3, 2026.
- What does Obsidian Therapeutics do?
- Obsidian Therapeutics, Inc. is a clinical biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases.
- Where is Obsidian Therapeutics based and how big is it?
- Obsidian Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 110 employees.
- Who are the decision-makers at Obsidian Therapeutics?
- Fundz holds 3 contacts at Obsidian Therapeutics, including the Director Regulatory Affairs CMC. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Obsidian Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Matisse Pharmaceuticals B.V raised $16M (Series A) on September 17, 2026.
- Lisata Therapeutics raised $352M (Series C) on September 17, 2026.
- FIZE Medical raised $20M (Series B) on September 17, 2026.
- H Clinical raised an undisclosed amount (Private Equity) on September 16, 2026.
- TRUE ARTIS raised $1.2M (Seed) on September 16, 2026.
- Medow Health raised $2.6M (Seed) on September 16, 2026.
Who to call at Obsidian Therapeutics, and when
A new round usually means Obsidian Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Obsidian Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Obsidian Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Obsidian Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Obsidian Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Obsidian Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.